nodes	percent_of_prediction	percent_of_DWPC	metapath
Clobetasol propionate—Prednisone—chronic obstructive pulmonary disease	0.182	0.506	CrCtD
Clobetasol propionate—Prednisolone—chronic obstructive pulmonary disease	0.178	0.494	CrCtD
Clobetasol propionate—CYP1A1—chronic obstructive pulmonary disease	0.124	0.509	CbGaD
Clobetasol propionate—CYP1A2—chronic obstructive pulmonary disease	0.12	0.491	CbGaD
Clobetasol propionate—NR3C1—Prednisolone—chronic obstructive pulmonary disease	0.0427	0.408	CbGbCtD
Clobetasol propionate—NR3C1—Prednisone—chronic obstructive pulmonary disease	0.0403	0.385	CbGbCtD
Clobetasol propionate—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0218	0.208	CbGbCtD
Clobetasol propionate—Ciclesonide—Prednisone—chronic obstructive pulmonary disease	0.00815	0.0329	CrCrCtD
Clobetasol propionate—Ciclesonide—Prednisolone—chronic obstructive pulmonary disease	0.00796	0.0321	CrCrCtD
Clobetasol propionate—Prednicarbate—Prednisone—chronic obstructive pulmonary disease	0.00641	0.0259	CrCrCtD
Clobetasol propionate—Prednicarbate—Prednisolone—chronic obstructive pulmonary disease	0.00626	0.0252	CrCrCtD
Clobetasol propionate—Beclomethasone—Prednisolone—chronic obstructive pulmonary disease	0.00626	0.0252	CrCrCtD
Clobetasol propionate—Clocortolone—Prednisolone—chronic obstructive pulmonary disease	0.00626	0.0252	CrCrCtD
Clobetasol propionate—Alclometasone—Prednisone—chronic obstructive pulmonary disease	0.00605	0.0244	CrCrCtD
Clobetasol propionate—Fluocinolone Acetonide—Prednisolone—chronic obstructive pulmonary disease	0.00591	0.0238	CrCrCtD
Clobetasol propionate—Alclometasone—Prednisolone—chronic obstructive pulmonary disease	0.00591	0.0238	CrCrCtD
Clobetasol propionate—Budesonide—Prednisone—chronic obstructive pulmonary disease	0.00589	0.0238	CrCrCtD
Clobetasol propionate—Amcinonide—Prednisone—chronic obstructive pulmonary disease	0.00589	0.0238	CrCrCtD
Clobetasol propionate—Fluoxymesterone—Prednisolone—chronic obstructive pulmonary disease	0.00575	0.0232	CrCrCtD
Clobetasol propionate—Amcinonide—Prednisolone—chronic obstructive pulmonary disease	0.00575	0.0232	CrCrCtD
Clobetasol propionate—Budesonide—Prednisolone—chronic obstructive pulmonary disease	0.00575	0.0232	CrCrCtD
Clobetasol propionate—Diflorasone—Prednisone—chronic obstructive pulmonary disease	0.00574	0.0232	CrCrCtD
Clobetasol propionate—Fludrocortisone—Prednisone—chronic obstructive pulmonary disease	0.00574	0.0232	CrCrCtD
Clobetasol propionate—Desonide—Prednisone—chronic obstructive pulmonary disease	0.00574	0.0232	CrCrCtD
Clobetasol propionate—Desonide—Prednisolone—chronic obstructive pulmonary disease	0.0056	0.0226	CrCrCtD
Clobetasol propionate—Prednisone—Prednisolone—chronic obstructive pulmonary disease	0.0056	0.0226	CrCrCtD
Clobetasol propionate—Diflorasone—Prednisolone—chronic obstructive pulmonary disease	0.0056	0.0226	CrCrCtD
Clobetasol propionate—Fludrocortisone—Prednisolone—chronic obstructive pulmonary disease	0.0056	0.0226	CrCrCtD
Clobetasol propionate—Paramethasone—Prednisone—chronic obstructive pulmonary disease	0.0056	0.0226	CrCrCtD
Clobetasol propionate—Paramethasone—Prednisolone—chronic obstructive pulmonary disease	0.00546	0.022	CrCrCtD
Clobetasol propionate—Desoximetasone—Prednisone—chronic obstructive pulmonary disease	0.00546	0.022	CrCrCtD
Clobetasol propionate—Mometasone—Prednisone—chronic obstructive pulmonary disease	0.00533	0.0215	CrCrCtD
Clobetasol propionate—Loteprednol—Prednisone—chronic obstructive pulmonary disease	0.00533	0.0215	CrCrCtD
Clobetasol propionate—Fluprednidene Acetate—Prednisone—chronic obstructive pulmonary disease	0.00533	0.0215	CrCrCtD
Clobetasol propionate—Triamcinolone—Prednisone—chronic obstructive pulmonary disease	0.00533	0.0215	CrCrCtD
Clobetasol propionate—Fluorometholone—Prednisone—chronic obstructive pulmonary disease	0.00533	0.0215	CrCrCtD
Clobetasol propionate—Desoximetasone—Prednisolone—chronic obstructive pulmonary disease	0.00533	0.0215	CrCrCtD
Clobetasol propionate—Dexamethasone—Prednisone—chronic obstructive pulmonary disease	0.00521	0.021	CrCrCtD
Clobetasol propionate—Rimexolone—Prednisone—chronic obstructive pulmonary disease	0.00521	0.021	CrCrCtD
Clobetasol propionate—Betamethasone—Prednisone—chronic obstructive pulmonary disease	0.00521	0.021	CrCrCtD
Clobetasol propionate—Loteprednol—Prednisolone—chronic obstructive pulmonary disease	0.0052	0.021	CrCrCtD
Clobetasol propionate—Fluorometholone—Prednisolone—chronic obstructive pulmonary disease	0.0052	0.021	CrCrCtD
Clobetasol propionate—Triamcinolone—Prednisolone—chronic obstructive pulmonary disease	0.0052	0.021	CrCrCtD
Clobetasol propionate—Mometasone—Prednisolone—chronic obstructive pulmonary disease	0.0052	0.021	CrCrCtD
Clobetasol propionate—Fluprednidene Acetate—Prednisolone—chronic obstructive pulmonary disease	0.0052	0.021	CrCrCtD
Clobetasol propionate—Dexamethasone—Prednisolone—chronic obstructive pulmonary disease	0.00508	0.0205	CrCrCtD
Clobetasol propionate—Rimexolone—Prednisolone—chronic obstructive pulmonary disease	0.00508	0.0205	CrCrCtD
Clobetasol propionate—Betamethasone—Prednisolone—chronic obstructive pulmonary disease	0.00508	0.0205	CrCrCtD
Clobetasol propionate—Methylprednisolone—Prednisone—chronic obstructive pulmonary disease	0.00498	0.0201	CrCrCtD
Clobetasol propionate—Prednisolone—Prednisone—chronic obstructive pulmonary disease	0.00488	0.0197	CrCrCtD
Clobetasol propionate—Methylprednisolone—Prednisolone—chronic obstructive pulmonary disease	0.00486	0.0196	CrCrCtD
Clobetasol propionate—Application site irritation—Tiotropium—chronic obstructive pulmonary disease	0.00174	0.0548	CcSEcCtD
Clobetasol propionate—Hyperadrenocorticism—Prednisolone—chronic obstructive pulmonary disease	0.00137	0.043	CcSEcCtD
Clobetasol propionate—Skin hypertrophy—Arformoterol—chronic obstructive pulmonary disease	0.00103	0.0323	CcSEcCtD
Clobetasol propionate—Skin hypertrophy—Formoterol—chronic obstructive pulmonary disease	0.00103	0.0323	CcSEcCtD
Clobetasol propionate—CYP1A1—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.000948	0.0823	CbGpPWpGaD
Clobetasol propionate—Secondary adrenocortical insufficiency—Prednisone—chronic obstructive pulmonary disease	0.000887	0.0279	CcSEcCtD
Clobetasol propionate—Application site reaction—Salbutamol—chronic obstructive pulmonary disease	0.000787	0.0247	CcSEcCtD
Clobetasol propionate—CYP1A2—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.000739	0.0642	CbGpPWpGaD
Clobetasol propionate—Rosacea—Prednisone—chronic obstructive pulmonary disease	0.000704	0.0221	CcSEcCtD
Clobetasol propionate—Cushing's syndrome—Prednisone—chronic obstructive pulmonary disease	0.000677	0.0213	CcSEcCtD
Clobetasol propionate—Skin striae—Prednisolone—chronic obstructive pulmonary disease	0.000666	0.0209	CcSEcCtD
Clobetasol propionate—Telangiectasia—Prednisone—chronic obstructive pulmonary disease	0.000653	0.0205	CcSEcCtD
Clobetasol propionate—Atrophy—Prednisolone—chronic obstructive pulmonary disease	0.000649	0.0204	CcSEcCtD
Clobetasol propionate—Acneiform eruption—Prednisone—chronic obstructive pulmonary disease	0.000609	0.0191	CcSEcCtD
Clobetasol propionate—Skin atrophy—Prednisone—chronic obstructive pulmonary disease	0.000509	0.016	CcSEcCtD
Clobetasol propionate—Dermatitis contact—Aminophylline—chronic obstructive pulmonary disease	0.000507	0.0159	CcSEcCtD
Clobetasol propionate—Leukoderma—Prednisolone—chronic obstructive pulmonary disease	0.000498	0.0156	CcSEcCtD
Clobetasol propionate—Skin striae—Prednisone—chronic obstructive pulmonary disease	0.000484	0.0152	CcSEcCtD
Clobetasol propionate—Glycosuria—Arformoterol—chronic obstructive pulmonary disease	0.000482	0.0152	CcSEcCtD
Clobetasol propionate—Glycosuria—Formoterol—chronic obstructive pulmonary disease	0.000482	0.0152	CcSEcCtD
Clobetasol propionate—Atrophy—Prednisone—chronic obstructive pulmonary disease	0.000472	0.0148	CcSEcCtD
Clobetasol propionate—Glycosuria—Salbutamol—chronic obstructive pulmonary disease	0.000455	0.0143	CcSEcCtD
Clobetasol propionate—Dermatitis acneiform—Prednisone—chronic obstructive pulmonary disease	0.00045	0.0141	CcSEcCtD
Clobetasol propionate—CYP1A1—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.000432	0.0375	CbGpPWpGaD
Clobetasol propionate—Hypertrichosis—Prednisone—chronic obstructive pulmonary disease	0.000405	0.0127	CcSEcCtD
Clobetasol propionate—CYP1A1—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.000393	0.0342	CbGpPWpGaD
Clobetasol propionate—Dermatitis contact—Arformoterol—chronic obstructive pulmonary disease	0.000386	0.0121	CcSEcCtD
Clobetasol propionate—Dermatitis contact—Formoterol—chronic obstructive pulmonary disease	0.000386	0.0121	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Roflumilast—chronic obstructive pulmonary disease	0.00038	0.0119	CcSEcCtD
Clobetasol propionate—Leukoderma—Prednisone—chronic obstructive pulmonary disease	0.000362	0.0114	CcSEcCtD
Clobetasol propionate—Pain in extremity—Tiotropium—chronic obstructive pulmonary disease	0.000351	0.011	CcSEcCtD
Clobetasol propionate—Dry skin—Tiotropium—chronic obstructive pulmonary disease	0.000322	0.0101	CcSEcCtD
Clobetasol propionate—CYP1A1—Estrogen Receptor Pathway—CYP1A2—chronic obstructive pulmonary disease	0.000293	0.0255	CbGpPWpGaD
Clobetasol propionate—Hyperglycaemia—Aminophylline—chronic obstructive pulmonary disease	0.000291	0.00913	CcSEcCtD
Clobetasol propionate—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	0.000291	0.0252	CbGpPWpGaD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.000285	0.00894	CcSEcCtD
Clobetasol propionate—CYP1A1—Oxidative Stress—SOD3—chronic obstructive pulmonary disease	0.000274	0.0238	CbGpPWpGaD
Clobetasol propionate—Hyperglycaemia—Tiotropium—chronic obstructive pulmonary disease	0.000274	0.00861	CcSEcCtD
Clobetasol propionate—Infection—Roflumilast—chronic obstructive pulmonary disease	0.000273	0.00857	CcSEcCtD
Clobetasol propionate—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.000267	0.00838	CcSEcCtD
Clobetasol propionate—Stinging—Prednisolone—chronic obstructive pulmonary disease	0.000261	0.00821	CcSEcCtD
Clobetasol propionate—Dry skin—Formoterol—chronic obstructive pulmonary disease	0.00026	0.00817	CcSEcCtD
Clobetasol propionate—Dry skin—Arformoterol—chronic obstructive pulmonary disease	0.00026	0.00817	CcSEcCtD
Clobetasol propionate—CYP1A1—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000248	0.0216	CbGpPWpGaD
Clobetasol propionate—Eye irritation—Prednisolone—chronic obstructive pulmonary disease	0.000248	0.00779	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Tiotropium—chronic obstructive pulmonary disease	0.00024	0.00753	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Tiotropium—chronic obstructive pulmonary disease	0.000239	0.00751	CcSEcCtD
Clobetasol propionate—CYP1A2—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000235	0.0204	CbGpPWpGaD
Clobetasol propionate—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.000228	0.00716	CcSEcCtD
Clobetasol propionate—CYP1A1—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000226	0.0196	CbGpPWpGaD
Clobetasol propionate—Hyperglycaemia—Formoterol—chronic obstructive pulmonary disease	0.000221	0.00695	CcSEcCtD
Clobetasol propionate—Hyperglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.000221	0.00695	CcSEcCtD
Clobetasol propionate—Delusion—Prednisone—chronic obstructive pulmonary disease	0.000217	0.00683	CcSEcCtD
Clobetasol propionate—Hyperglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.000209	0.00656	CcSEcCtD
Clobetasol propionate—CYP1A1—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000208	0.018	CbGpPWpGaD
Clobetasol propionate—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000202	0.00636	CcSEcCtD
Clobetasol propionate—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.0002	0.0174	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.0002	0.0173	CbGpPWpGaD
Clobetasol propionate—Oedema peripheral—Formoterol—chronic obstructive pulmonary disease	0.000193	0.00607	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Arformoterol—chronic obstructive pulmonary disease	0.000193	0.00607	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.000193	0.00606	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.000193	0.00606	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Montelukast—chronic obstructive pulmonary disease	0.000191	0.00601	CcSEcCtD
Clobetasol propionate—Glycosuria—Prednisone—chronic obstructive pulmonary disease	0.00019	0.00596	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.000189	0.00593	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000184	0.00579	CcSEcCtD
Clobetasol propionate—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.000182	0.0158	CbGpPWpGaD
Clobetasol propionate—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.000182	0.00572	CcSEcCtD
Clobetasol propionate—Infection—Aminophylline—chronic obstructive pulmonary disease	0.000182	0.00572	CcSEcCtD
Clobetasol propionate—NR3C1—Transcription factor regulation in adipogenesis—LEP—chronic obstructive pulmonary disease	0.00018	0.0157	CbGpPWpGaD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000179	0.00562	CcSEcCtD
Clobetasol propionate—CYP1A1—Oxidative Stress—GCLC—chronic obstructive pulmonary disease	0.000179	0.0155	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000173	0.015	CbGpPWpGaD
Clobetasol propionate—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000173	0.00544	CcSEcCtD
Clobetasol propionate—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000173	0.00544	CcSEcCtD
Clobetasol propionate—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000172	0.00541	CcSEcCtD
Clobetasol propionate—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000172	0.00539	CcSEcCtD
Clobetasol propionate—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000168	0.00527	CcSEcCtD
Clobetasol propionate—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000155	0.00487	CcSEcCtD
Clobetasol propionate—CYP1A1—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000154	0.0134	CbGpPWpGaD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000144	0.00454	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000144	0.00454	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000141	0.00444	CcSEcCtD
Clobetasol propionate—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000141	0.00442	CcSEcCtD
Clobetasol propionate—Infection—Formoterol—chronic obstructive pulmonary disease	0.000139	0.00435	CcSEcCtD
Clobetasol propionate—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000139	0.00435	CcSEcCtD
Clobetasol propionate—CYP1A2—Estrogen Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000136	0.0118	CbGpPWpGaD
Clobetasol propionate—Infection—Montelukast—chronic obstructive pulmonary disease	0.000136	0.00426	CcSEcCtD
Clobetasol propionate—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000135	0.00425	CcSEcCtD
Clobetasol propionate—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000135	0.00425	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000135	0.00424	CcSEcCtD
Clobetasol propionate—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000133	0.00417	CcSEcCtD
Clobetasol propionate—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000131	0.00411	CcSEcCtD
Clobetasol propionate—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00013	0.00407	CcSEcCtD
Clobetasol propionate—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000128	0.00402	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000127	0.004	CcSEcCtD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000127	0.011	CbGpPWpGaD
Clobetasol propionate—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000125	0.00392	CcSEcCtD
Clobetasol propionate—CYP1A1—Oxidative Stress—HMOX1—chronic obstructive pulmonary disease	0.000124	0.0107	CbGpPWpGaD
Clobetasol propionate—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000123	0.00385	CcSEcCtD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—IL13—chronic obstructive pulmonary disease	0.000122	0.0106	CbGpPWpGaD
Clobetasol propionate—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000122	0.00384	CcSEcCtD
Clobetasol propionate—CYP1A1—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.00012	0.0104	CbGpPWpGaD
Clobetasol propionate—Pain—Formoterol—chronic obstructive pulmonary disease	0.000119	0.00375	CcSEcCtD
Clobetasol propionate—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000119	0.00375	CcSEcCtD
Clobetasol propionate—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.00371	CcSEcCtD
Clobetasol propionate—Pain—Montelukast—chronic obstructive pulmonary disease	0.000117	0.00367	CcSEcCtD
Clobetasol propionate—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000116	0.00364	CcSEcCtD
Clobetasol propionate—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000116	0.00363	CcSEcCtD
Clobetasol propionate—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000115	0.00363	CcSEcCtD
Clobetasol propionate—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000115	0.00999	CbGpPWpGaD
Clobetasol propionate—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000115	0.00361	CcSEcCtD
Clobetasol propionate—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000113	0.00354	CcSEcCtD
Clobetasol propionate—CYP1A2—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.00011	0.00959	CbGpPWpGaD
Clobetasol propionate—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000109	0.00342	CcSEcCtD
Clobetasol propionate—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000109	0.00342	CcSEcCtD
Clobetasol propionate—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000108	0.0034	CcSEcCtD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CYP1A2—chronic obstructive pulmonary disease	0.000107	0.00927	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—CYP1A2—chronic obstructive pulmonary disease	0.000107	0.00927	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000107	0.00927	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000105	0.00909	CbGpPWpGaD
Clobetasol propionate—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000103	0.00323	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000103	0.00323	CcSEcCtD
Clobetasol propionate—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000102	0.00321	CcSEcCtD
Clobetasol propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—HDAC2—chronic obstructive pulmonary disease	0.000102	0.00886	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—HDAC2—chronic obstructive pulmonary disease	0.000101	0.00877	CbGpPWpGaD
Clobetasol propionate—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000101	0.00316	CcSEcCtD
Clobetasol propionate—CYP1A1—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	9.98e-05	0.00867	CbGpPWpGaD
Clobetasol propionate—Pruritus—Arformoterol—chronic obstructive pulmonary disease	9.86e-05	0.0031	CcSEcCtD
Clobetasol propionate—Pruritus—Formoterol—chronic obstructive pulmonary disease	9.86e-05	0.0031	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	9.7e-05	0.00305	CcSEcCtD
Clobetasol propionate—Pruritus—Montelukast—chronic obstructive pulmonary disease	9.66e-05	0.00304	CcSEcCtD
Clobetasol propionate—CYP1A2—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	9.62e-05	0.00836	CbGpPWpGaD
Clobetasol propionate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—chronic obstructive pulmonary disease	9.34e-05	0.00811	CbGpPWpGaD
Clobetasol propionate—Pruritus—Salbutamol—chronic obstructive pulmonary disease	9.31e-05	0.00293	CcSEcCtD
Clobetasol propionate—CYP1A2—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	9.26e-05	0.00804	CbGpPWpGaD
Clobetasol propionate—Erythema—Prednisolone—chronic obstructive pulmonary disease	9.25e-05	0.00291	CcSEcCtD
Clobetasol propionate—CYP1A1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	8.82e-05	0.00766	CbGpPWpGaD
Clobetasol propionate—Rash—Formoterol—chronic obstructive pulmonary disease	8.79e-05	0.00276	CcSEcCtD
Clobetasol propionate—Rash—Arformoterol—chronic obstructive pulmonary disease	8.79e-05	0.00276	CcSEcCtD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—EDN1—chronic obstructive pulmonary disease	8.79e-05	0.00763	CbGpPWpGaD
Clobetasol propionate—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	8.78e-05	0.00276	CcSEcCtD
Clobetasol propionate—Dermatitis—Formoterol—chronic obstructive pulmonary disease	8.78e-05	0.00276	CcSEcCtD
Clobetasol propionate—Headache—Arformoterol—chronic obstructive pulmonary disease	8.73e-05	0.00274	CcSEcCtD
Clobetasol propionate—Headache—Formoterol—chronic obstructive pulmonary disease	8.73e-05	0.00274	CcSEcCtD
Clobetasol propionate—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	8.7e-05	0.00273	CcSEcCtD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—IL10—chronic obstructive pulmonary disease	8.69e-05	0.00755	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	8.63e-05	0.00749	CbGpPWpGaD
Clobetasol propionate—Rash—Montelukast—chronic obstructive pulmonary disease	8.61e-05	0.0027	CcSEcCtD
Clobetasol propionate—Dermatitis—Montelukast—chronic obstructive pulmonary disease	8.6e-05	0.0027	CcSEcCtD
Clobetasol propionate—Headache—Montelukast—chronic obstructive pulmonary disease	8.56e-05	0.00269	CcSEcCtD
Clobetasol propionate—CYP1A1—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	8.51e-05	0.00739	CbGpPWpGaD
Clobetasol propionate—NR3C1—Transcription factor regulation in adipogenesis—TNF—chronic obstructive pulmonary disease	8.35e-05	0.00725	CbGpPWpGaD
Clobetasol propionate—Rash—Salbutamol—chronic obstructive pulmonary disease	8.3e-05	0.00261	CcSEcCtD
Clobetasol propionate—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	8.29e-05	0.00261	CcSEcCtD
Clobetasol propionate—Headache—Salbutamol—chronic obstructive pulmonary disease	8.25e-05	0.00259	CcSEcCtD
Clobetasol propionate—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—chronic obstructive pulmonary disease	8.12e-05	0.00705	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	8.09e-05	0.00703	CbGpPWpGaD
Clobetasol propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—chronic obstructive pulmonary disease	7.73e-05	0.00671	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	7.63e-05	0.00663	CbGpPWpGaD
Clobetasol propionate—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	7.59e-05	0.00238	CcSEcCtD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—MMP1—chronic obstructive pulmonary disease	7.39e-05	0.00642	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	7.32e-05	0.00635	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—PLAU—chronic obstructive pulmonary disease	7.25e-05	0.0063	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	7.15e-05	0.00621	CbGpPWpGaD
Clobetasol propionate—NR3C1—Adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	7.01e-05	0.00609	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	6.99e-05	0.00607	CbGpPWpGaD
Clobetasol propionate—Alopecia—Prednisone—chronic obstructive pulmonary disease	6.82e-05	0.00214	CcSEcCtD
Clobetasol propionate—NR3C1—Circadian Clock—SERPINE1—chronic obstructive pulmonary disease	6.8e-05	0.00591	CbGpPWpGaD
Clobetasol propionate—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	6.78e-05	0.00213	CcSEcCtD
Clobetasol propionate—NR3C1—Transcription factor regulation in adipogenesis—IL6—chronic obstructive pulmonary disease	6.74e-05	0.00585	CbGpPWpGaD
Clobetasol propionate—Erythema—Prednisone—chronic obstructive pulmonary disease	6.72e-05	0.00211	CcSEcCtD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	6.6e-05	0.00573	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—MMP1—chronic obstructive pulmonary disease	6.51e-05	0.00565	CbGpPWpGaD
Clobetasol propionate—Pain—Prednisolone—chronic obstructive pulmonary disease	6.46e-05	0.00203	CcSEcCtD
Clobetasol propionate—CYP1A1—PPARA activates gene expression—CTGF—chronic obstructive pulmonary disease	5.76e-05	0.00501	CbGpPWpGaD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	5.68e-05	0.00179	CcSEcCtD
Clobetasol propionate—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—chronic obstructive pulmonary disease	5.64e-05	0.0049	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	5.63e-05	0.00489	CbGpPWpGaD
Clobetasol propionate—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	5.56e-05	0.00175	CcSEcCtD
Clobetasol propionate—Infection—Prednisone—chronic obstructive pulmonary disease	5.45e-05	0.00171	CcSEcCtD
Clobetasol propionate—Skin disorder—Prednisone—chronic obstructive pulmonary disease	5.33e-05	0.00167	CcSEcCtD
Clobetasol propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—chronic obstructive pulmonary disease	4.99e-05	0.00433	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	4.94e-05	0.00429	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	4.94e-05	0.00429	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	4.94e-05	0.00429	CbGpPWpGaD
Clobetasol propionate—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	4.93e-05	0.00155	CcSEcCtD
Clobetasol propionate—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	4.87e-05	0.00423	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	4.82e-05	0.00418	CbGpPWpGaD
Clobetasol propionate—Rash—Prednisolone—chronic obstructive pulmonary disease	4.76e-05	0.0015	CcSEcCtD
Clobetasol propionate—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	4.76e-05	0.00149	CcSEcCtD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—CXCL8—chronic obstructive pulmonary disease	4.75e-05	0.00413	CbGpPWpGaD
Clobetasol propionate—Headache—Prednisolone—chronic obstructive pulmonary disease	4.73e-05	0.00149	CcSEcCtD
Clobetasol propionate—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	4.62e-05	0.00402	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	4.58e-05	0.00397	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.47e-05	0.00388	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.42e-05	0.00384	CbGpPWpGaD
Clobetasol propionate—NR3C1—Adipogenesis—LEP—chronic obstructive pulmonary disease	4.36e-05	0.00378	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—MMP9—chronic obstructive pulmonary disease	4.3e-05	0.00373	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	4.29e-05	0.00372	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—chronic obstructive pulmonary disease	4.19e-05	0.00364	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	4.05e-05	0.00352	CbGpPWpGaD
Clobetasol propionate—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	4.04e-05	0.00127	CcSEcCtD
Clobetasol propionate—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	4e-05	0.00347	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	3.94e-05	0.00342	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—chronic obstructive pulmonary disease	3.89e-05	0.00338	CbGpPWpGaD
Clobetasol propionate—Pruritus—Prednisone—chronic obstructive pulmonary disease	3.88e-05	0.00122	CcSEcCtD
Clobetasol propionate—CYP1A1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.71e-05	0.00323	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.66e-05	0.00318	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	3.63e-05	0.00315	CbGpPWpGaD
Clobetasol propionate—NR3C1—Endoderm Differentiation—TGFB1—chronic obstructive pulmonary disease	3.62e-05	0.00315	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—TGFB1—chronic obstructive pulmonary disease	3.54e-05	0.00308	CbGpPWpGaD
Clobetasol propionate—Rash—Prednisone—chronic obstructive pulmonary disease	3.46e-05	0.00109	CcSEcCtD
Clobetasol propionate—Dermatitis—Prednisone—chronic obstructive pulmonary disease	3.46e-05	0.00109	CcSEcCtD
Clobetasol propionate—Headache—Prednisone—chronic obstructive pulmonary disease	3.44e-05	0.00108	CcSEcCtD
Clobetasol propionate—NR3C1—Adipogenesis—SERPINE1—chronic obstructive pulmonary disease	3.42e-05	0.00297	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	3.38e-05	0.00293	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	3.33e-05	0.00289	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	3.27e-05	0.00284	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	3.27e-05	0.00284	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	3.24e-05	0.00281	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.14e-05	0.00273	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	3.11e-05	0.0027	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	3.11e-05	0.0027	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	3.1e-05	0.00269	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.1e-05	0.00269	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.06e-05	0.00265	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—TP53—chronic obstructive pulmonary disease	2.92e-05	0.00253	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	2.85e-05	0.00247	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.85e-05	0.00247	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	2.82e-05	0.00245	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.81e-05	0.00244	CbGpPWpGaD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	2.74e-05	0.00238	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	2.73e-05	0.00237	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—IL6—chronic obstructive pulmonary disease	2.67e-05	0.00232	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—TP53—chronic obstructive pulmonary disease	2.57e-05	0.00223	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	2.5e-05	0.00217	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	2.4e-05	0.00208	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—IL6—chronic obstructive pulmonary disease	2.35e-05	0.00204	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	2.32e-05	0.00201	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—APIP—chronic obstructive pulmonary disease	2.17e-05	0.00189	CbGpPWpGaD
Clobetasol propionate—NR3C1—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	2.16e-05	0.00187	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	2.13e-05	0.00185	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	2.08e-05	0.00181	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	2.08e-05	0.00181	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	2.03e-05	0.00177	CbGpPWpGaD
Clobetasol propionate—NR3C1—Adipogenesis—TNF—chronic obstructive pulmonary disease	2.02e-05	0.00175	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	2e-05	0.00174	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	1.98e-05	0.00172	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	1.98e-05	0.00172	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.98e-05	0.00172	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.95e-05	0.00169	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.82e-05	0.00158	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.79e-05	0.00155	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	1.74e-05	0.00151	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.72e-05	0.00149	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.7e-05	0.00147	CbGpPWpGaD
Clobetasol propionate—NR3C1—Adipogenesis—IL6—chronic obstructive pulmonary disease	1.63e-05	0.00141	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.55e-05	0.00134	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.44e-05	0.00125	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.43e-05	0.00124	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	1.41e-05	0.00122	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—GC—chronic obstructive pulmonary disease	1.4e-05	0.00122	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	1.38e-05	0.0012	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—CTGF—chronic obstructive pulmonary disease	1.32e-05	0.00114	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.3e-05	0.00113	CbGpPWpGaD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	1.25e-05	0.00108	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—HDAC2—chronic obstructive pulmonary disease	1.23e-05	0.00107	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	9.87e-06	0.000857	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.17e-06	0.000796	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	8.92e-06	0.000775	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.29e-06	0.00072	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.64e-06	0.000664	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	7.56e-06	0.000656	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.04e-06	0.000612	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	6.89e-06	0.000599	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	6.61e-06	0.000574	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.35e-06	0.000552	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	6.01e-06	0.000522	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.3e-06	0.00046	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.23e-06	0.000454	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.87e-06	0.000423	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.87e-06	0.000423	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	4.82e-06	0.000418	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.49e-06	0.00039	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	4.4e-06	0.000382	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.38e-06	0.000293	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.33e-06	0.000289	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—ALB—chronic obstructive pulmonary disease	3.14e-06	0.000272	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.1e-06	0.00027	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	3e-06	0.000261	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.94e-06	0.000256	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	2e-06	0.000174	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.91e-06	0.000166	CbGpPWpGaD
